Legis Daily

Extending Temporary Emergency Scheduling of Fentanyl Analogues Act

USA117th CongressHR-2630| House 
| Updated: 10/19/2021
Chris Pappas

Chris Pappas

Democratic Representative

New Hampshire

Cosponsors (3)
Van Taylor (Republican)Gus M. Bilirakis (Republican)Frank Pallone (Democratic)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Extending Temporary Emergency Scheduling of Fentanyl Analogues Act This bill extends until October 22, 2021, the temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances in schedule I of the Controlled Substances Act. The temporary order expires on May 6, 2021.

Bill Text Versions

View Text
5 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 16, 2021
Introduced in House
Apr 16, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 19, 2021
Referred to the Subcommittee on Health.
Apr 21, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Apr 21, 2021
Considered under suspension of the rules. (consideration: CR H2025-2029)
Apr 21, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 2630.
Apr 21, 2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2025)
Apr 21, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2025)
Apr 21, 2021
Motion to reconsider laid on the table Agreed to without objection.
Apr 21, 2021
The title of the measure was amended. Agreed to without objection.
Apr 22, 2021
Received in the Senate, read twice.
Apr 29, 2021
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S2323-2324)
Apr 29, 2021
Passed Senate without amendment by Voice Vote. (consideration: CR S2323-2324)
Apr 29, 2021
Message on Senate action sent to the House.
Apr 30, 2021
Presented to President.
May 4, 2021
Signed by President.
May 4, 2021
Became Public Law No: 117-12.
Oct 19, 2021
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • April 16, 2021
    Introduced in House


  • April 16, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • April 19, 2021
    Referred to the Subcommittee on Health.


  • April 21, 2021
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • April 21, 2021
    Considered under suspension of the rules. (consideration: CR H2025-2029)


  • April 21, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 2630.


  • April 21, 2021
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2025)


  • April 21, 2021
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2025)


  • April 21, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • April 21, 2021
    The title of the measure was amended. Agreed to without objection.


  • April 22, 2021
    Received in the Senate, read twice.


  • April 29, 2021
    Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S2323-2324)


  • April 29, 2021
    Passed Senate without amendment by Voice Vote. (consideration: CR S2323-2324)


  • April 29, 2021
    Message on Senate action sent to the House.


  • April 30, 2021
    Presented to President.


  • May 4, 2021
    Signed by President.


  • May 4, 2021
    Became Public Law No: 117-12.


  • October 19, 2021
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Crime and Law Enforcement

Related Bills

  • HR 117-6119: Further Extending Government Funding Act
  • S 117-1216: Temporary Extension of Fentanyl Scheduling Act of 2021
  • HR 117-6617: Further Additional Extending Government Funding Act
  • S 117-2789: Extending Government Funding and Delivering Emergency Assistance Act
  • HR 117-5305: Extending Government Funding and Delivering Emergency Assistance Act
  • HR 117-2430: Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act
Drug trafficking and controlled substances

Extending Temporary Emergency Scheduling of Fentanyl Analogues Act

USA117th CongressHR-2630| House 
| Updated: 10/19/2021
Extending Temporary Emergency Scheduling of Fentanyl Analogues Act This bill extends until October 22, 2021, the temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances in schedule I of the Controlled Substances Act. The temporary order expires on May 6, 2021.

Bill Text Versions

View Text
5 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 16, 2021
Introduced in House
Apr 16, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 19, 2021
Referred to the Subcommittee on Health.
Apr 21, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Apr 21, 2021
Considered under suspension of the rules. (consideration: CR H2025-2029)
Apr 21, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 2630.
Apr 21, 2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2025)
Apr 21, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2025)
Apr 21, 2021
Motion to reconsider laid on the table Agreed to without objection.
Apr 21, 2021
The title of the measure was amended. Agreed to without objection.
Apr 22, 2021
Received in the Senate, read twice.
Apr 29, 2021
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S2323-2324)
Apr 29, 2021
Passed Senate without amendment by Voice Vote. (consideration: CR S2323-2324)
Apr 29, 2021
Message on Senate action sent to the House.
Apr 30, 2021
Presented to President.
May 4, 2021
Signed by President.
May 4, 2021
Became Public Law No: 117-12.
Oct 19, 2021
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • April 16, 2021
    Introduced in House


  • April 16, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • April 19, 2021
    Referred to the Subcommittee on Health.


  • April 21, 2021
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • April 21, 2021
    Considered under suspension of the rules. (consideration: CR H2025-2029)


  • April 21, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 2630.


  • April 21, 2021
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2025)


  • April 21, 2021
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2025)


  • April 21, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • April 21, 2021
    The title of the measure was amended. Agreed to without objection.


  • April 22, 2021
    Received in the Senate, read twice.


  • April 29, 2021
    Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S2323-2324)


  • April 29, 2021
    Passed Senate without amendment by Voice Vote. (consideration: CR S2323-2324)


  • April 29, 2021
    Message on Senate action sent to the House.


  • April 30, 2021
    Presented to President.


  • May 4, 2021
    Signed by President.


  • May 4, 2021
    Became Public Law No: 117-12.


  • October 19, 2021
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Chris Pappas

Chris Pappas

Democratic Representative

New Hampshire

Cosponsors (3)
Van Taylor (Republican)Gus M. Bilirakis (Republican)Frank Pallone (Democratic)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

Crime and Law Enforcement

Related Bills

  • HR 117-6119: Further Extending Government Funding Act
  • S 117-1216: Temporary Extension of Fentanyl Scheduling Act of 2021
  • HR 117-6617: Further Additional Extending Government Funding Act
  • S 117-2789: Extending Government Funding and Delivering Emergency Assistance Act
  • HR 117-5305: Extending Government Funding and Delivering Emergency Assistance Act
  • HR 117-2430: Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug trafficking and controlled substances